Patrones de prescripción del ácido acetilsalicílico / Prescribing patterns of acetylsalicylic acid
Rev. colomb. cardiol
;
22(3): 127-135, mayo-jun. 2015. ilus, tab
Article
in Spanish
| LILACS, COLNAL
| ID: lil-757958
RESUMEN
Objetivo:
Determinar los patrones de prescripción del ácido acetilsalicílico, además de los costos y variables asociados a su utilización en una población de pacientes afiliados al Sistema General de Seguridad Social en Salud (SGSSS) de Colombia en el año 2014.Métodos:
Estudio descriptivo de corte transversal. Mediante una base de datos de aproximadamente 3,5 millones de pacientes afiliados al SGSSS de Colombia en 88 ciudades, se seleccionaron pacientes a quienes se les dispensó ácido acetilsalicílico entre el 1.° de enero el30 de marzo de 2014 de manera ininterrumpida. Se analizaron variables sociodemográficas, farmacológicas y de comedicación.Resultados:
Un total de 69.807 pacientes recibieron aspirina durante el periodo evaluado, con una edad promedio de 66,7 ± 12,1 años; el 57,1% eran hombres; el 99,8% tomaban alguna comedicación el 94,8% antihipertensivos; el 22,4% antihipertensivos, antidiabéticos e hipolipemiantes de manera concomitante; el 95,4% estaban en monoterapia con aspirina, y el 4,6% recibían terapia combinada con 2 o más antiagregantes plaquetarios. El análisis multivariado encontró mayor probabilidad de recibir terapia combinada en Bogotá, Barranquilla y Cartagena. La dosis usual fue 100 mg/día y la dosis diaria, definida por 1.000 habitantes/día, fue 19,9.Conclusiones:
La prescripción de ácido acetilsalicílico en Colombia se realizó a las dosis recomendadas por la Organización Mundial de la Salud para la prevención del riesgo cardiovascular, y su proporción de uso es inferior cuando se compara con la de otras poblaciones.ABSTRACT
Objective:
Determine the prescribing patterns of acetylsalicylic acid, costs and variables associated with its use in a population of patients affiliated to the Colombian Health System in 2014.Methods:
Cross-sectional descriptive study. Using a database of approximately 3.5 million patients beneficiaries of the Colombian Health System in 88 cities; patients who were dispensed with acetylsalicylic acid continuously since 1st of January to 30th of March 2014 were selected. Sociodemographic, co-medication and pharmacologic variables were analyzed.Results:
A total of 69,807 patients were receiving aspirin during the assessment period with a mean age of 66.7 ± 12.1 years; 57.1% were male; 99.8% received some co-medication 94.8% received antihypertensive agents; 22.4% were receiving antihypertensive, antidiabetic and lipid-lowering drugs concomitantly; 95.4% were receiving monotherapy with aspirin, and 4.6% received combination therapy with 2 or more antiplatelet agents. Multivariate analysis found that it was more likely to receive combination therapy in Bogota, Barranquilla and Cartagena. The usual dose was 100 mg and defined daily dose/1,000 inhabitants/day was 19.9.Conclusions:
The prescription of acetylsalicylic acid in Colombia was made at recommended doses by the WHO for the prevention of cardiovascular risk; and their frequency of use was lower when compared with other populations.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Aspirin
/
Pharmacoepidemiology
Type of study:
Etiology study
/
Observational study
/
Prevalence study
/
Risk factors
Limits:
Aged
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. colomb. cardiol
Journal subject:
Cardiology
Year:
2015
Type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Universidad Tecnológica de Pereira/CO
Similar
MEDLINE
...
LILACS
LIS